BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vilarrasa E, Puig L. Psoriasis: Biologic treatment and liver disease. World J Dermatol 2014; 3(4): 76-85 [DOI: 10.5314/wjd.v3.i4.76]
URL: https://www.wjgnet.com/2218-6190/full/v3/i4/76.htm
Number Citing Articles
1
April W. Armstrong, Mark Lebwohl, Richard B. Warren, Howard Sofen, Shinichi Imafuku, Mamitaro Ohtsuki, Lynda Spelman, Thierry Passeron, Kim A. Papp, Renata M. Kisa, John Vaile, Victoria Berger, Eleni Vritzali, Kim Hoyt, Matthew J. Colombo, Julie Scotto, Subhashis Banerjee, Bruce Strober, Diamant Thaçi, Andrew Blauvelt. Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis For Up to 3 YearsJAMA Dermatology 2024;  doi: 10.1001/jamadermatol.2024.4688
2
Luigi Francesco Iannone, Luigi Bennardo, Caterina Palleria, Roberta Roberti, Caterina De Sarro, Maria Diana Naturale, Stefano Dastoli, Luca Donato, Antonia Manti, Giancarlo Valenti, Domenico D’Amico, Santo D’Attola, Adele Emanuela De Francesco, Vincenzo Bosco, Eugenio Donato Di Paola, Steven Paul Nisticò, Rita Citraro, Emilio Russo, Giovambattista De Sarro, Stefanos Bonovas. Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance studyPLOS ONE 2020; 15(11): e0241575 doi: 10.1371/journal.pone.0241575
3
Collin M. Blattner, Soham P. Chaudhari, John Young, Jenny E. Murase. A dermatologist guide to immunogenicityInternational Journal of Women's Dermatology 2016; 2(3): 77 doi: 10.1016/j.ijwd.2016.05.001